drugset / Trial / NCT06546111

Clinical Study to Evaluate the Possible Efficacy and Safety of Diosmin and Hesperidin Combined Therapy in Patients With Helicobacter Pylori Infection

NCT06546111

Phase 1/2 Recruiting 46 enrolled Sadat City University
RandomizedParallel-groupDouble-blindTreatment

Summary

This study intends to assess the possible effectiveness and safety of Diosmin and Hesperidin combination in patients with Helicobacter pylori Infection through evaluating its effect on stool antigen test and serum levels of inflammatory biomarkers as(TNF-A and MDA).

Timeline

Start
2024-10-01
Primary completion
2025-10-01
Completion
2026-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Diosmin Small molecule Oral
Subject Hesperidin Small molecule Oral